Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B.

Source:http://linkedlifedata.com/resource/pubmed/id/10803838

Download in:

View as

General Info

PMID
10803838